Key Market Indicators
Swiss pharmaceutical production is projected to surge to €36.9 billion by 2028, up from €28.8 billion in 2023. This represents an average annual growth rate of 3.9%. The sector has demonstrated robust expansion since 2014, with an annual increase of 7%. In the European context, Italy, Spain, and Austria follow Switzerland, ranking second, third, and fourth respectively in pharmaceutical production.
Latest reports
Switzerland Pharmaceuticals Market Report- Q1 2025
In the first quarter of 2025, the pharmaceuticals market in Switzerland exhibited dynamic growth and strategic shifts, driven by advancements in biopharmaceuticals, specialty...
Switzerland Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the pharmaceutical industry in Switzerland has encountered multifaceted dynamics, shaped by economic, regulatory, and competitive factors. These...
Switzerland Pharmaceuticals Market Report - Q4 2024
The Swiss pharmaceuticals market in the fourth quarter of 2024 demonstrates dynamic growth driven by the expansion of biopharmaceuticals and a strong focus...
